ALL
57
-3
HP
68
-7
CB
51
-10
CI
66
-3
ABBV
59
-9
ECL
37
-2
WFC
58
12
CMI
56
-2
KR
36
-5
FTI
69
-4
FOX
53
2
CNX
73
-3
L
52
-3
M
30
2
HBI
28
7
GT
34
4
KMX
35
5
PCG
64
-2
NWSA
58
2
HUM
70
-3
ALL
57
-3
HP
68
-7
CB
51
-10
CI
66
-3
ABBV
59
-9
ECL
37
-2
WFC
58
12
CMI
56
-2
KR
36
-5
FTI
69
-4
FOX
53
2
CNX
73
-3
L
52
-3
M
30
2
HBI
28
7
GT
34
4
KMX
35
5
PCG
64
-2
NWSA
58
2
HUM
70
-3
Financhill
Back

Astellas Pharma Quote, Financials, Valuation and Earnings

3 Stocks That Could Double or Triple in the Months Ahead

Click here to claim your free report now.
Sell
42

ALPMY
Astellas Pharma

Last Price:
13.85
Seasonality Move:
-0.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Did It Again: This Could be Bigger than Tesla

Click here.

Astellas Pharma Price Quote

$13.85

Astellas Pharma Key Stats

Sell
42
Astellas Pharma (ALPMY) is a Sell
Day range:
$13.79 - $14.00
52-week range:
$12.82 - $16.91
Dividend yield:
1.56%
P/E ratio:
34.58
P/S ratio:
2.29
P/B ratio:
2.28%
Volume:
84.7K
Avg. volume:
136.4K
1-year change:
5.81%
Market cap:
$24.9B
Revenue:
$11.2B
EPS:
$0.42

How Much Does Astellas Pharma Make?

Is Astellas Pharma Growing As A Company?

  • What Is Astellas Pharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.07%
  • What Is Astellas Pharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.28%

Astellas Pharma Stock Price Performance

  • Did Astellas Pharma Stock Go Up Last Month?
    Astellas Pharma share price went down by -8.4% last month
  • Did ALPMY's Share Price Rise Over The Last Year?
    ALPMY share price rose by 5.81% over the past 1 year

What Is Astellas Pharma 52-Week High & Low?

Astellas Pharma Price To Free Cash Flow

Is It Risky To Buy Astellas Pharma?

  • How Much Debt Does Astellas Pharma Have?
    Total long term debt quarterly is $2.5B
  • How Much Cash Does Astellas Pharma Have?
    Cash and short term investments quarterly total is $4.2B
  • What Is Astellas Pharma’s Book Value Per Share?
    Book value per share is 6.07

Is Astellas Pharma Cash Flow Positive?

  • What Is ALPMY Cash Flow From Operations?
    Cash flow from operations (TTM) is $2.1B
  • What Is Astellas Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $113.7M
  • What Is Astellas Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$567.7M

Astellas Pharma Return On Invested Capital

  • Is Management Doing A Good Job?
    ALPMY return on invested capital is 6.35%
  • What Is Astellas Pharma Return On Assets?
    ROA measures how assets are converting to revenues and is 4.06%
  • What Is ALPMY Return On Equity?
    ROE is a measure of profitability and is 6.63%

Astellas Pharma Earnings Date & Stock Price

Astellas Pharma Competitors

  • Who Are Astellas Pharma's Competitors?
    Below is a list of companies who compete with Astellas Pharma or are related in some way:
    • Healios KK (HLOSF)
    • PeptiDream Inc (PPTDF)
    • Sosei Group Corp (SOLTF)
    • Stemcell Holdings Inc (STMM)
    • Takeda Pharmaceutical Co Ltd (TAK)

Astellas Pharma Dividend Yield

Astellas Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 27.99% 0%
Revenue: -7.25% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many ALPMY shares are owned by institutional investors?
    973K ALPMY shares are owned by institutional investors
  • How many ALPMY shares are owned by insiders?
    0 ALPMY shares are owned by insiders